CN107446995A - 用于扩增样品中多个目标dna序列的引物组及其应用 - Google Patents
用于扩增样品中多个目标dna序列的引物组及其应用 Download PDFInfo
- Publication number
- CN107446995A CN107446995A CN201710546580.8A CN201710546580A CN107446995A CN 107446995 A CN107446995 A CN 107446995A CN 201710546580 A CN201710546580 A CN 201710546580A CN 107446995 A CN107446995 A CN 107446995A
- Authority
- CN
- China
- Prior art keywords
- sequence
- primer
- specific
- modification
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 44
- 238000012986 modification Methods 0.000 claims abstract description 40
- 230000004048 modification Effects 0.000 claims abstract description 33
- 230000003321 amplification Effects 0.000 claims abstract description 27
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 27
- 239000000539 dimer Substances 0.000 claims abstract description 24
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 25
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 108020004414 DNA Proteins 0.000 claims description 16
- 230000000295 complement effect Effects 0.000 claims description 11
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 11
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 claims description 10
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 claims description 10
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 10
- 238000000137 annealing Methods 0.000 claims description 10
- 229960002685 biotin Drugs 0.000 claims description 10
- 235000020958 biotin Nutrition 0.000 claims description 10
- 239000011616 biotin Substances 0.000 claims description 10
- 229960005156 digoxin Drugs 0.000 claims description 10
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 10
- 125000001153 fluoro group Chemical group F* 0.000 claims description 9
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 7
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 7
- 125000004149 thio group Chemical group *S* 0.000 claims description 7
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 6
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 239000011324 bead Substances 0.000 claims description 6
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 6
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 6
- 230000005291 magnetic effect Effects 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000005365 aminothiol group Chemical group 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- -1 thio-modification Chemical compound 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 238000005034 decoration Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims 1
- 239000000047 product Substances 0.000 description 66
- 150000007523 nucleic acids Chemical class 0.000 description 46
- 108020004707 nucleic acids Proteins 0.000 description 44
- 102000039446 nucleic acids Human genes 0.000 description 44
- 239000002585 base Substances 0.000 description 37
- 239000000523 sample Substances 0.000 description 26
- 238000009396 hybridization Methods 0.000 description 14
- 239000007787 solid Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 238000007403 mPCR Methods 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000011049 pearl Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 3
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 3
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 3
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003636 chemical group Chemical group 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 102100029075 Exonuclease 1 Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241000283953 Lagomorpha Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000012350 deep sequencing Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
染色体 | 个数 | 染色体 | 个数 |
chr1 | 75 | chr12 | 65 |
chr2 | 40 | chr13 | 20 |
chr3 | 60 | chr14 | 10 |
chr4 | 105 | chr15 | 25 |
chr5 | 55 | chr16 | 35 |
chr6 | 65 | chr17 | 40 |
chr7 | 30 | chr18 | 10 |
chr8 | 65 | chr19 | 25 |
chr9 | 30 | chr20 | 35 |
chr10 | 65 | chr21 | 15 |
chr11 | 100 | chr22 | 30 |
引物特点 | 捕获效率 | 100x覆盖率 |
Tm标准差≤1℃ | 80.01% | 84.37% |
1℃<Tm标准差≤2℃ | 76.34% | 78.80% |
2℃<Tm标准差≤5℃ | 71.24% | 72.02% |
Tm标准差>5℃ | 60.27% | 64.99% |
引物特点 | 捕获效率 | 100×覆盖率 |
3’端-4处氟代基团 | 93.10% | 100% |
3’端-4处甲基修饰 | 89.23% | 98.87% |
3’端-4处碱基硫代 | 82.77% | 91.15% |
3’端-4脱氧尿嘧啶(dU) | 90.92% | 99.57% |
3’端-4脱氧次黄嘌呤(dI) | 94.03% | 99.91% |
对照(正常引物) | 79.21% | 84.09% |
引物特点 | 捕获效率 | 100×覆盖率 |
Tm(目标产物)-Tm(非目标产物)≤5℃ | 62.35% | 67.03% |
5℃<Tm(目标产物)-Tm(非目标产物)≤10℃ | 70.01% | 73.45% |
Tm(目标产物)-Tm(非目标产物)>10℃ | 78.84% | 82.47% |
引物特点 | 捕获效率 | 100×覆盖率 |
Tm(目标产物)-Tm(二聚体)≤5℃ | 45.21% | 50.74% |
5℃<Tm(目标产物)-Tm(二聚体)≤10℃ | 61.27% | 68.17% |
Tm(目标产物)-Tm(二聚体)>10℃ | 78.64% | 83.55% |
引物特点 | 捕获效率 | 100×覆盖率 |
Tm(目标产物)-Tm(发卡结构)≤5℃ | 64.28% | 68.36% |
5℃<Tm(目标产物)-Tm(发卡结构)≤10℃ | 75.09% | 80.94% |
Tm(目标产物)-Tm(发卡结构)>10℃ | 79.98% | 83.49% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710546580.8A CN107446995B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710546580.8A CN107446995B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
CN201610293653.2A CN105925678B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610293653.2A Division CN105925678B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107446995A true CN107446995A (zh) | 2017-12-08 |
CN107446995B CN107446995B (zh) | 2020-06-02 |
Family
ID=56835122
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610293653.2A Active CN105925678B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
CN201710546580.8A Active CN107446995B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610293653.2A Active CN105925678B (zh) | 2016-05-06 | 2016-05-06 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN105925678B (zh) |
AU (2) | AU2016405379A1 (zh) |
WO (1) | WO2017190487A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108251502A (zh) * | 2017-12-27 | 2018-07-06 | 深圳华大基因股份有限公司 | 一种外周血游离肿瘤dna的富集方法、试剂盒及其应用 |
CN110592210A (zh) * | 2019-08-13 | 2019-12-20 | 上海艾汭得基因科技有限公司 | 检测brca1/2全外显序列的序列引物及设计方法 |
CN110714077A (zh) * | 2019-08-13 | 2020-01-21 | 上海艾汭得基因科技有限公司 | 同时检测brca1/2外显子序列和化疗用药位点的引物及应用 |
CN110734974A (zh) * | 2019-08-13 | 2020-01-31 | 上海艾汭得基因科技有限公司 | 一种癌症化疗用药snp位点组合以及检测引物 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105925678B (zh) * | 2016-05-06 | 2021-10-12 | 艾吉泰康生物科技(北京)有限公司 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
CN107254541B (zh) * | 2017-08-03 | 2020-05-08 | 广州万德基因医学科技有限公司 | 用于扩增cfDNA样品中多个目标的NGS建库引物池及应用 |
CN110295252A (zh) * | 2019-05-22 | 2019-10-01 | 东莞博盛生物科技有限公司 | 提高特异性的检测犬副流感的反应液、引物对、探针及试剂盒 |
CN112011599A (zh) * | 2020-09-07 | 2020-12-01 | 苏州贝康医疗器械有限公司 | 用于减少非特异性扩增的pcr引物组及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1718737A (zh) * | 2004-07-09 | 2006-01-11 | 南华大学 | 一种可消除非特异性条带的pcr方法以及利用该方法制备的rt-pcr芯片 |
WO2014110528A1 (en) * | 2013-01-13 | 2014-07-17 | Unitaq Bio | Methods and compositions for pcr using blocked and universal primers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001055454A1 (en) * | 2000-01-28 | 2001-08-02 | Althea Technologies, Inc. | Methods for analysis of gene expression |
CN105925678B (zh) * | 2016-05-06 | 2021-10-12 | 艾吉泰康生物科技(北京)有限公司 | 用于扩增样品中多个目标dna序列的引物组及其应用 |
-
2016
- 2016-05-06 CN CN201610293653.2A patent/CN105925678B/zh active Active
- 2016-05-06 CN CN201710546580.8A patent/CN107446995B/zh active Active
- 2016-11-21 AU AU2016405379A patent/AU2016405379A1/en active Pending
- 2016-11-21 WO PCT/CN2016/106608 patent/WO2017190487A1/zh active Application Filing
- 2016-11-21 AU AU2016102399A patent/AU2016102399A4/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1718737A (zh) * | 2004-07-09 | 2006-01-11 | 南华大学 | 一种可消除非特异性条带的pcr方法以及利用该方法制备的rt-pcr芯片 |
WO2014110528A1 (en) * | 2013-01-13 | 2014-07-17 | Unitaq Bio | Methods and compositions for pcr using blocked and universal primers |
Non-Patent Citations (1)
Title |
---|
徐阳炎等: "提高窖蛋白基因扩增特异性的逆转录聚合酶链防范", 《中华医学遗传学杂志》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108251502A (zh) * | 2017-12-27 | 2018-07-06 | 深圳华大基因股份有限公司 | 一种外周血游离肿瘤dna的富集方法、试剂盒及其应用 |
CN108251502B (zh) * | 2017-12-27 | 2021-12-24 | 深圳华大基因股份有限公司 | 一种外周血游离肿瘤dna的富集方法、试剂盒及其应用 |
CN110592210A (zh) * | 2019-08-13 | 2019-12-20 | 上海艾汭得基因科技有限公司 | 检测brca1/2全外显序列的序列引物及设计方法 |
CN110714077A (zh) * | 2019-08-13 | 2020-01-21 | 上海艾汭得基因科技有限公司 | 同时检测brca1/2外显子序列和化疗用药位点的引物及应用 |
CN110734974A (zh) * | 2019-08-13 | 2020-01-31 | 上海艾汭得基因科技有限公司 | 一种癌症化疗用药snp位点组合以及检测引物 |
CN110592210B (zh) * | 2019-08-13 | 2023-10-31 | 阔然生物医药科技(上海)有限公司 | 检测brca1/2全外显序列的序列引物及设计方法 |
CN110734974B (zh) * | 2019-08-13 | 2023-10-31 | 阔然生物医药科技(上海)有限公司 | 一种癌症化疗用药snp位点组合以及检测引物 |
CN110714077B (zh) * | 2019-08-13 | 2023-10-31 | 阔然生物医药科技(上海)有限公司 | 同时检测brca1/2外显子序列和化疗用药位点的引物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN107446995B (zh) | 2020-06-02 |
AU2016405379A1 (en) | 2019-01-03 |
WO2017190487A1 (zh) | 2017-11-09 |
AU2016102399A4 (en) | 2019-05-16 |
CN105925678B (zh) | 2021-10-12 |
CN105925678A (zh) | 2016-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107446995A (zh) | 用于扩增样品中多个目标dna序列的引物组及其应用 | |
EP3234200B1 (en) | Method for targeted depletion of nucleic acids using crispr/cas system proteins | |
CN109310784B (zh) | 用于制备和使用指导核酸的方法和组合物 | |
US9879312B2 (en) | Selective enrichment of nucleic acids | |
US8986958B2 (en) | Methods for generating target specific probes for solution based capture | |
CN105925671B (zh) | 一种从核酸样品富集目标序列核酸的方法 | |
CN105647907B (zh) | 一种用于靶向杂交捕获的修饰性dna杂交探针的制备方法 | |
US20160251712A1 (en) | Sequential Sequencing | |
CN107760772A (zh) | 用于核酸配对末端测序的方法、组合物、系统、仪器和试剂盒 | |
CN112680797A (zh) | 一种去除高丰度rna的测序文库及其构建方法 | |
US20070072223A1 (en) | Compositions and methods for purifying nucleic acids | |
CN106191256A (zh) | 一种针对目标区域进行dna甲基化测序的方法 | |
CN102559856B (zh) | 去除测序文库中的载体片段的方法 | |
US11414686B2 (en) | Stoichiometric nucleic acid purification using randomer capture probe libraries | |
US9315807B1 (en) | Genome selection and conversion method | |
CN113454235A (zh) | 经改进的核酸靶标富集和相关方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200430 Address after: 314100 Building No. 2, 371 Hongye Road, Dayun Town, Jiashan County, Jiaxing City, Zhejiang Province 101 Applicant after: Aiji Taikang (Jiaxing) Biotechnology Co.,Ltd. Address before: 102206 Beijing City, Changping District Beijing city Zhongguancun Life Science Park Life Road No. 8 School District No. 9 Building 3 Room 301 Applicant before: Igenetech Biotech (Beijing) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Primer sets for amplifying multiple target DNA sequences in samples and their applications Effective date of registration: 20230410 Granted publication date: 20200602 Pledgee: Zhejiang Jiashan rural commercial bank Limited by Share Ltd. science and technology sub branch Pledgor: Aiji Taikang (Jiaxing) Biotechnology Co.,Ltd. Registration number: Y2023450000056 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20200602 Pledgee: Zhejiang Jiashan rural commercial bank Limited by Share Ltd. science and technology sub branch Pledgor: Aiji Taikang (Jiaxing) Biotechnology Co.,Ltd. Registration number: Y2023450000056 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Primer sets for amplifying multiple target DNA sequences in samples and their applications Granted publication date: 20200602 Pledgee: Zhejiang Jiashan rural commercial bank Limited by Share Ltd. science and technology sub branch Pledgor: Aiji Taikang (Jiaxing) Biotechnology Co.,Ltd. Registration number: Y2024330000405 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |